Flukomp (Flucomp)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceParacetamol + Phenylephrine + PheniramineParacetamol + Phenylephrine + Pheniramine
Dosage form: & nbspPowder for solution for oral administration (lemon, orange)
Composition:

Each sachet contains:

Active substances:

Flukomp

Flukomp

Paracetamol

325 mg

650 mg

Pheniramine maleate

20 mg

20 mg

Phenylephrine hydrochloride

10 mg

10 mg

Excipients:

lemon acid

270 mg

547 mg

sodium hydrocitrate

195 mg

390 mg

dextrin

317 mg

642 mg

maltodextrin

50.2 mg

100.4 mg

sucrose (sugar)

1242.5 mg

2500 mg

aspartame

40 mg

80 mg

flavor ("lemon" or "orange")

30 mg

60 mg

dye ("quinoline yellow" or "sunset sunset")

0.3 mg

0.6 mg
Description:
Granulated powder uniformly yellow or orange colors from characteristic a faint smell of lemon or orange.
Pharmacotherapeutic group:Remedy for elimination of symptoms of ARVI and "colds" (analgesic non-narcotic means + alpha-adrenomimetic + H1-histamine receptor blocker).
ATX: & nbsp

N.02.B.E   Anilides

N.02.B.E.51   Paracetamol in combination with other drugs, excluding psycholeptics

Pharmacodynamics:

Combined drug, has antipyretic, anti-cognitive, analgesic and anti-allergic effects. Eliminates the symptoms of "colds" (hyperthermia, chills, headache, runny nose, stuffy nose, sneezing, pain in the muscles). Paracetamol has antipyretic and analgesic effect: reduces pain syndrome, which is observed in catarrhal conditions - sore throat, headache, muscle and joint pain, reduces heat. Phenylephrine has vasoconstrictive effect - reduces edema and hyperemia of the mucous membranes of the upper respiratory tract and accessory sinuses. Pheniramine has anti-allergic effect: it removes the itch of the eyes, nose and throat, swelling and flushing of the mucous membranes of the nasal cavity, nasopharynx and paranasal sinuses, reduces exudative manifestations.

Indications:

Symptomatic treatment of ARVI and other "cold" diseases, including influenza.

Contraindications:

Hypersensitivity to the components of the drug, pregnancy, lactation, children under 12 years,deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption, phenylketonuria.

Carefully:Arterial hypertension, diabetes mellitus, angle-closure glaucoma, severe liver or kidney disease, prostatic hyperplasia, deficiency of glucose-6-phosphate dehydrogenase.
Dosing and Administration:

Inside. Adults and children over 12 years old - dissolve the contents of one sachet in 1 glass of boiled hot water. You can add sugar to taste. To use in a hot kind. Repeated dose can be taken every 4 hours (no more than three doses within 24 hours).

Possible application at any time of the day, but the best effect is taking the drug before going to bed, at night. Treatment should not exceed 3 days (then the drug is canceled, regardless of the availability of a doctor's consultation).

Side effects:

Possible dry mouth, nausea, vomiting, epigastric pain, drowsiness, fatigue, decreased speed of psychomotor reactions, increased excitability, palpitations, increased blood pressure, dizziness, sleep disorders, mydriasis, paresis of accommodation, increased intraocular pressure, urinary retention, allergic reaction,anemia, thrombocytopenia, leukopenia, agranulocytosis, with prolonged use of high doses - hepatotoxic and nephrotoxic effects, hemolytic anemia, methemoglobinemia, pancytopenia are possible.

Overdose:

Symptoms: pallor of the skin, anorexia, nausea, vomiting, pain in the epigastric region; hepatotoxic and nephrotoxic action, in severe cases - hepatic insufficiency, encephalopathy and coma.

Treatment: gastric lavage, the appointment of activated charcoal, symptomatic therapy, the introduction of donators SH-groups and precursors of glutathione-methionine synthesis 8-9 hours after an overdose and N-acetylcysteine ​​after 12 hours.

Interaction:

Not compatible with monoamine oxidase inhibitors. Barbiturates, phenytoin, carbamazepine, rifampicin, zidovudine and other inducers of microsomal liver enzymes increase the risk of hepatotoxic effect of paracetamol.

Strengthens the action of sedatives, ethanol. Ethanol strengthens the sedative effect of phenyramine. Antidepressants, antiparkinsonic and antipsychotic agents, phenothiazine derivatives increase the risk of urinary retention, dry mouth.
Special instructions:

During the treatment it is necessary to refrain from using ethanol (it is possible to develop hepatotoxic action), driving motor vehicles and practicing other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.

Form release / dosage:

Powder for solution for ingestion (lemon, orange).

Packaging:2.5 g (with a dosage of 325 mg + 20 mg + 10 mg) or 5 g (at a dosage of 650 mg + 20 mg + 10 mg) in a heat-sealable packet from a combination film material or from a combined multilayered material or from a foil laminated packing. By 5, 10, 20, 30, 40 or 50 bags together with instructions for medical use are placed in a pack of cardboard.
Storage conditions:

In a dry, protected from light place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

2 years.

Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:Without recipe
Registration number:PL-000874
Date of registration:18.10.2011
The owner of the registration certificate:OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC Russia
Manufacturer: & nbsp
Information update date: & nbsp11.09.2015
Illustrated instructions
    Instructions
    Up